InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Lippoldt Darin, Directeur Juridique. Officer active across 1 company, notably Neurocrine Biosciences INC. Aggregated, 36 filings have been logged. Split: 0 buy · 13 sells. Total volume traded: €3.6m. History available since 10 December 2021. The latest transaction was filed on 9 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Lippoldt Darin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations36 total
10,000 shares@ US$81.490.0045% mcap8.5% of flowCommon StockSEC:0001504783-26-000017:0
10,000 shares@ US$179.60140.0099% mcap18.7% of flowCommon StockSEC:0001504783-26-000017:1
200 sharesCommon StockSEC:0001504783-26-000015:0
200 sharesCommon StockSEC:0001504783-26-000015:1
8,110 sharesCommon StockSEC:0001504783-26-000015:2
8,110 sharesCommon StockSEC:0001504783-26-000015:3
1,690 sharesCommon StockSEC:0001504783-26-000015:4
1,690 sharesCommon StockSEC:0001504783-26-000015:5
1,792 shares0Common StockSEC:0001504783-26-000011:0
2,373 shares0Common StockSEC:0001504783-26-000007:0
3,349 shares@ US$35.991.7% of flowCommon StockSEC:0001504783-26-000004:0
4,376 shares@ US$43.240.0011% mcap37.3% of flowCommon StockSEC:0001504783-25-000006:0
190 shares0Common StockSEC:0000914475-25-000065:0
1,727 shares0Common StockSEC:0000914475-25-000050:0
2,373 shares0Common StockSEC:0000914475-25-000026:0
2,996 shares@ US$79.023.5% of flowCommon StockSEC:0000914475-24-000185:0
7,004 shares@ US$79.028.2% of flowCommon StockSEC:0000914475-24-000168:0
1,098 shares@ US$132.99492.2% of flowCommon StockSEC:0000914475-24-000074:0
1,041 shares@ US$142.16632.2% of flowCommon StockSEC:0000914475-24-000048:0
1,250 shares@ US$140.64782.6% of flowCommon StockSEC:0000914475-24-000029:0
10,000 shares@ US$79.0211.7% of flowCommon StockSEC:0000914475-24-000011:0
20,830 shares@ US$43.2413.4% of flowCommon StockSEC:0000914475-23-000082:0
10,919 shares@ US$112.273218.0% of flowCommon StockSEC:0001209191-23-056907:0
190 shares0Common StockSEC:0001209191-23-047966:0
2,132 shares@ US$107.3883.4% of flowCommon StockSEC:0001209191-23-047138:0
25 of 36 declarations
About Lippoldt Darin
Lippoldt Darin is Directeur Juridique at Neurocrine Biosciences INC, where he is also Chief Legal Officer. Across 36 filings in total, the sampled recent filings cover the period from 2021-12-14 to 2026-07-13, with 0 in buys and 3634744 in sells, and the most common transaction nature is Option exercise.
